Delivery Order SPE2DB20D3103-SPE2DB22FL9H0
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $1,405.28 firm-fixed-price delivery order is for the supply of 4558884048 - Loteprednol Etabonate 0.5% Eye Drops in 5 mL containers. The contract has an ultimate completion date of October 26, 2022 and was awarded on October 25, 2022. This contract is not designated as a set-aside. Amerisourcebergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $3,672.09, is for the delivery of Loteprednol Etabonate 0.5% eye drops. The contract is a firm fixed-price delivery order with a completion date of December 19, 2022. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,449.86 Firm Fixed Price Delivery Order is for the supply of 4,564,730,207 units of Loteprednol Etabonate 0.5% ophthalmic drops, with a performance period ending on May 29, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a Single-Award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
- This federal contract award is for the delivery of loteprednol etabonate 0.5% eye drops, in 5 ml quantities, to the Defense Logistics Agency (DLA). The $2,143.44 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on March 1, 2023, with an ultimate completion date of March 2, 2023. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Loteprednol Etabonate 0.5% ophthalmic drops in 5 mL quantities, with a ceiling value of $2,508.45. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The contract calls for completion by May 7, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- This is a $1,866.34 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of loteprednol etabonate 0.5% eye drops, a prescription medication, and has an ultimate completion date of September 20, 2024. Amerisourcebergen holds significant Indefinite Delivery Contracts (IDCs) with DLA and the Department of Justice Federal Bureau of Investigation for providing a wide range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,102.82 firm fixed-price delivery order is for the supply of Loteprednol Etabonate 0.5% ophthalmic drops (5ml). The contract was awarded on September 7, 2021, with a completion date of September 8, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc. and is registered in the System...
- The Defense Logistics Agency awarded a $1,842.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Loteprednol Etabonate 0.2% ophthalmic drops in 5 mL quantities. The contract, which represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), is non-competitive and scheduled for completion by August 1, 2025. Performance will be fulfilled...
- This firm fixed-price delivery order, valued at $1,404.70, was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The order is for the supply of 0.5% lubricant eye drops in 30-count packages. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary contract vehicle for...
- The Defense Logistics Agency awarded a delivery order valued at $3,096.94 to AmerisourceBergen Drug Corp for Loteprednol Etabonate 0.5% ophthalmic drops (5 mL) on August 18, 2025, with completion scheduled for August 19, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The pharmaceutical product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FL9H0Delivery Order
The Defense Logistics Agency (DLA) awarded a $9,971.22 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of loteprednol etabonate 0.5% eye drops. This delivery order falls under a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., is a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems, and holds additional IDCs with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.0k | 12/9/21 |